Lenvatinib 10mg
Our product range includes a wide range of lenvatinib lenvakast 10mg capsules.
Lenvatinib lenvakast 10mg Capsules
Request Callback
₹ 4000 Get Latest Price
| Manufactured By | Aprazer company |
| Type of Cancer | Kidney Cancer |
| Brand | Aprazer Company |
| Packaging Type | Box |
| Usage/Application | Cancer Treatment |
| Product Type | Capsule |
| Generic Name | Lenvatinib |
| Dose Strength | 10 MG |
Minimum order quantity: 1 Box
Lenvatinib is indicated for the treatment of patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma (DTC), refractory to radioactive iodine (RAI).
LENVIMA treatment should be initiated and supervised by a health care professional experienced in the use of anticancer therapies.
LENVIMA treatment should be initiated and supervised by a health care professional experienced in the use of anticancer therapies.
X
Contact Us
Ruchika Sethi (Director)
Magicine Pharma
02, Ground Floor, Gagandeep Building
Rajendra Place, New Delhi - 110008, Delhi, India
Send Email